Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: waverider who wrote (1918)	4/30/1998 5:56:00 PM
From: wlheatmoon	Read Replies (1) \| Respond to of 5736

The heel stick blood draw does test for other problems in newborns other than bilirubin. However, if bilirubin is noted to be a problem, there is continuous testing until the problem resolves. CCSI's device can be used to eliminate the invasive monitoring. It can even be used as a portable device to determine the infant's bilirubin levels at home. Many infants are sent home after they're found to have elevated bilirubin and once treatments are initiated, the therapy can be continued at home. Instead of having the baby come to the clinic every day for bilirubin tests, a nurse can visit the family with this device and determine the level noninvasively. That's just one scenario. Another one is obviously for infants in the hospital. Once the bilirubin level is noted to be elevated, CCSI's noninvasive device can be used for monitoring the level and for determining the efficacy of therapy. Just my thoughts. Good luck. mike PS--OH YES, HIGHER LOWS LOL, it has been a long day!! <GGG>

To: waverider who wrote (1918)	4/30/1998 6:02:00 PM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 5736

Drawing Blood From techstocks.com .....By law, hospitals are required to do a PKU test on newborns (requires drawing blood). Therefore, no matter how great the CCSI device is, blood will always be drawn from newborns...... .......Bilirubin is fairly common in babies and can be very dangerous (cause mental retardation). If it is suspected, then blood is drawn and sent to the lab. The lab takes up to 1 hour or so to report their findings. In the mean time, the baby is put under a Bilirubin lamp (no big deal). It is fairly common to continue to monitor the Bilirubin levels in the baby to see how they are progressing........ Also, in determining the size of the market for bilirubin testing CCSI did not include the test that is a part of a general panel. See techstocks.com "......individual bilirubin blood tests on newborn infants (heelsticks), which are not part of a general panel blood test....." ========= There is a ton of info located at these links - which are located on the very first introduction post for this board - check them out: Consolidated Information On This Company Located At These Links as of 4/98 TECHNOLOGY OVERVIEW, MFG, NON-MEDICAL ASPECTS, PATENTS: Message 4151860 NEWS RELEASES, CONFERENCE CALLS & SHAREHOLDER LETTERS: Message 4151896 BILIRUBIN MONITOR, FDA 510K, JAUNDICE REFERENCES: Message 4151923 FINANCIALS, STATISTICS & COMPETITION: Message 4151945